Treating patients with severe sepsis.
Wheeler
A P
AP
Center for Lung Research, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232-2650, USA.
Bernard
G R
GR
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D006801:Humans; D009102:Multiple Organ Failure / Q000209:etiology; D009747:Nutritional Physiological Phenomena; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000209:etiology / Q000628:therapy; D018805:Sepsis / Q000145:classification / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D012772:Shock, Septic / Q000209:etiology / Q000628:therapy; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014662:Vasoconstrictor Agents